These data showed that enhanced endogenous ATP concentration, via activation of purinergic receptors P2RY2 is related to the pathogenesis of LPS-induced lung inflammation in mouse model, and might be a potential therapeutic target for treatment of ARDS patients and predictably evaluate new treatments on organ function in ARDS. The gene discussed is P2RY2; the disease is acute respiratory distress syndrome.